Luo Zhuo

Luo Zhuo

Auto-generated profile, based on publicly available information

Luo Zhuo

Guangxi Key Laboratory for Bioactive Molecules Research and Evaluation & College of Pharmacy, Guangxi Medical University, 22 Shuangyong Road, Nanning, 530021, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LZLuo Zhuo
Luo Zhuo
XCXiaobing Chen
Xiaobing Chen
YSYan Sun
Yan Sun
YWYanli Wang
Yanli Wang
YSYuanfeng Shi
Yuanfeng Shi
XLXiaomin Li
Xiaomin Li
Pyroptosis, an inflammatory form of programmed cell death, is the initiating event of sepsis and results in immune imbalance by releasing IL‐1β and IL‐18 in the early stages. Studies show that enhancing autophagy via genetic manipulation can inhibit pyroptosis and prolong the survival of a sepsis animal model, indicating a possible therapeutic strategy against sepsis. However, almost no study so far has achieved pyroptosis inhibition via pharmacological autophagy induction in a sepsis disease model. To this end, we established an in vitro sepsis model by stimulating primary human umbilical vein endothelial cells (HUVECs) with lipopolysaccharide (LPS), and analyzed the effect of the autophagy agonist rapamycin (RAPA) on pyroptosis. Phorbol 12‐myristate 13‐acetate‐ (PMA‐) activated human THP‐1 cells were used as the positive control. LPS significantly increased the levels of the pyroptotic protein Gasdermin D (GSDMD), cysteinyl aspartate‐specific proteinase 1 (caspase‐1), secreted LDH, IL‐1β, and IL‐18. RAPA treatment downregulated the above factors and enhanced autophagy in the LPS‐stimulated HUVECs and THP‐1 cells. This study shows that RAPA abrogates LPS‐mediated increase in IL‐1β and IL‐18 by inhibiting pyroptosis and enhancing autophagy.

25 August 2020 in Computational and Mathematical Methods in Medicine
Verified
Journal Article
Open access
PDF file
LBLin Bu
Lin Bu
ZWZi-Wen Wang
Zi-Wen Wang
SHShuqun Hu
Shuqun Hu
WZWen-Jing Zhao
Wen-Jing Zhao
XGXiao-Juan Geng
Xiao-Juan Geng
XLXiaomin Li
Xiaomin Li
Neonatal sepsis is one of the most prevalent causes of death of the neonates. However, the mechanisms underlying neonatal sepsis remained unclear. The present study identified a total of 1128 upregulated mRNAs and 1008 downregulated mRNAs, 28 upregulated lncRNAs, and 61 downregulated lncRNAs in neonatal sepsis. Then, we constructed PPI networks to identify key regulators in neonatal sepsis, including ITGAM, ITGAX, TLR4, ITGB2, SRC, ELANE, RPLP0, RPS28, RPL26, and RPL27. lncRNA coexpression analysis showed HS.294603, LOC391811, C12ORF47, LOC729021, HS.546375, HNRPA1L-2, LOC158345, and HS.495041 played important roles in the progression of neonatal sepsis. Bioinformatics analysis showed DEGs were involved in the regulation cellular extravasation, acute inflammatory response, macrophage activation of NF-kappa B signaling pathway, TNF signaling pathway, HIF-1 signaling pathway, Toll-like receptor signaling pathway, and ribosome, RNA transport, and spliceosome. lncRNAs were involved in regulating ribosome, T cell receptor signaling pathway, RNA degradation, insulin resistance, ribosome biogenesis in eukaryotes, and hematopoietic cell lineage. We thought this study provided useful information for identifying novel therapeutic markers for neonatal sepsis.


1 February 2019 in Inflammation
Verified
Journal Article
Closed access
PDF file
TZTing Zhou
Ting Zhou
YSYan Sun
Yan Sun
YWYanli Wang
Yanli Wang
XCXiaobing Chen
Xiaobing Chen
LZLuo Zhuo
Luo Zhuo
JSJiaxin Shi
Jiaxin Shi